stella
beta
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer — Stella
Recruiting
Back to Ovary Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
View full record on ClinicalTrials.gov